Powered by

Eventide Funds Announces 2016 Results

BOSTON, MA --(Marketwired - February 03, 2017) - Eventide Funds announced 2016 results for the Eventide Gilead Fund (NASDAQ: ETGLX) (NASDAQ: ETILX) (NASDAQ: ETAGX) (NASDAQ: ETCGX), Eventide Healthcare & Life Sciences Fund (NASDAQ: ETNHX) (NASDAQ: ETIHX) (NASDAQ: ETAHX) (NASDAQ: ETCHX), and Eventide Multi-Asset Income Fund (NASDAQ: ETNMX) (NASDAQ: ETIMX) (NASDAQ: ETAMX) (NASDAQ: ETCMX):


Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox